{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:17:48Z","timestamp":1791562668126,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016818","name":"UT-Battelle","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DK075166-01"],"award-info":[{"award-number":["DK075166-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006206","name":"Biological and Environmental Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006228","name":"Oak Ridge National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013503","name":"Canadian Society for Molecular Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013503","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.jbc.2023.104886","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T20:46:31Z","timestamp":1685738791000},"page":"104886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors"],"prefix":"10.1016","volume":"299","author":[{"given":"Andrey","family":"Kovalevsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3929-6841","authenticated-orcid":false,"given":"Annie","family":"Aniana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leighton","family":"Coates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter V.","family":"Bonnesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nashaat T.","family":"Nashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0052-1899","authenticated-orcid":false,"given":"John M.","family":"Louis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2023.104886_bib1","series-title":"Therapeutics and COVID-19: Living Guideline, 13 January 2023","year":"2023"},{"key":"10.1016\/j.jbc.2023.104886_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/toxsci\/kfab130","article-title":"COVID-19 therapeutics and vaccines: a race to save lives","volume":"185","author":"Bebenek","year":"2022","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.jbc.2023.104886_bib3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S1473-3099(22)00816-7","article-title":"Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB","volume":"23","author":"Uraki","year":"2023","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jbc.2023.104886_bib4","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s41564-022-01143-7","article-title":"SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway","volume":"7","author":"Willett","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jbc.2023.104886_bib5","doi-asserted-by":"crossref","first-page":"103004","DOI":"10.1016\/j.jbc.2023.103004","article-title":"Structural basis of nirmatrelvir and ensitrelvir activity against naturally occurring polymorphisms of the SARS-CoV-2 Main Protease","volume":"299","author":"Noske","year":"2023","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104886_bib6","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1021\/acsomega.2c03881","article-title":"Novel investigational anti-SARS-CoV-2 agent ensitrelvir \"S-217622\": a very promising potential universal broad-spectrum antiviral at the therapeutic frontline of coronavirus species","volume":"8","author":"Eltayb","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.jbc.2023.104886_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.add7197","article-title":"Nirmatrelvir-resistant SARS-CoV-2 variants with high fitness in an infectious cell culture system","volume":"8","author":"Zhou","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jbc.2023.104886_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1465-9921-6-8","article-title":"Molecular mechanisms of severe acute respiratory syndrome (SARS)","volume":"6","author":"Groneberg","year":"2005","journal-title":"Respir. Res."},{"key":"10.1016\/j.jbc.2023.104886_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.abb3405","article-title":"Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.104886_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.605236","article-title":"Structural characterization of SARS-CoV-2: where we are, and where we need to Be","volume":"7","author":"Mariano","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.jbc.2023.104886_bib11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/jmv.25762","article-title":"The establishment of reference sequence for SARS-CoV-2 and variation analysis","volume":"92","author":"Wang","year":"2020","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.jbc.2023.104886_bib12","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10930-020-09901-4","article-title":"The proteins of severe acute respiratory syndrome coronavirus-2 (SARS CoV-2 or n-COV19), the cause of COVID-19","volume":"39","author":"Yoshimoto","year":"2020","journal-title":"Protein J."},{"key":"10.1016\/j.jbc.2023.104886_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s13238-010-0011-4","article-title":"Liberation of SARS-CoV main protease from the viral polyprotein: N-Terminal autocleavage does not depend on the mature dimerization mode","volume":"1","author":"Chen","year":"2010","journal-title":"Protein Cell"},{"key":"10.1016\/j.jbc.2023.104886_bib14","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1111\/febs.12222","article-title":"Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins","volume":"280","author":"Muramatsu","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.jbc.2023.104886_bib15","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/s42003-022-03910-y","article-title":"Autoprocessing and oxyanion loop reorganization upon GC373 and nirmatrelvir binding of monomeric SARS-CoV-2 main protease catalytic domain","volume":"5","author":"Nashed","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2023.104886_bib16","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41564-022-01119-7","article-title":"An orally available M(pro) inhibitor is effective against wild-type SARS-CoV-2 and variants including Omicron","volume":"7","author":"Quan","year":"2022","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.jbc.2023.104886_bib17","doi-asserted-by":"crossref","first-page":"6499","DOI":"10.1021\/acs.jmedchem.2c00117","article-title":"Discovery of S-217622, a noncovalent oral SARS-CoV-2 3CL protease inhibitor clinical candidate for treating COVID-19","volume":"65","author":"Unoh","year":"2022","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.jbc.2023.104886_bib18","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.jbc.2023.104886_bib19","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1038\/s41467-020-16954-7","article-title":"Structural plasticity of SARS-CoV-2 3CL M(pro) active site cavity revealed by room temperature X-ray crystallography","volume":"11","author":"Kneller","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104886_bib20","doi-asserted-by":"crossref","first-page":"17365","DOI":"10.1074\/jbc.AC120.016154","article-title":"Unusual zwitterionic catalytic site of SARS-CoV-2 main protease revealed by neutron crystallography","volume":"295","author":"Kneller","year":"2020","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104886_bib21","doi-asserted-by":"crossref","first-page":"e1001084","DOI":"10.1371\/journal.pcbi.1001084","article-title":"Dynamically-driven inactivation of the catalytic machinery of the SARS 3C-like protease by the N214A mutation on the extra domain","volume":"7","author":"Shi","year":"2011","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.jbc.2023.104886_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1021\/bi1008497","article-title":"A\u00a0structural study of norovirus 3C protease specificity: binding of a designed active site-directed peptide inhibitor","volume":"50","author":"Hussey","year":"2011","journal-title":"Biochemistry"},{"key":"10.1016\/j.jbc.2023.104886_bib23","doi-asserted-by":"crossref","first-page":"11754","DOI":"10.1128\/JVI.01348-12","article-title":"Broad-spectrum antivirals against 3C or 3C-like proteases of picornaviruses, noroviruses, and coronaviruses","volume":"86","author":"Kim","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.jbc.2023.104886_bib24","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s12551-022-01020-x","article-title":"Functional dynamics of SARS-CoV-2 3C-like protease as a member of clan PA","volume":"14","author":"Kidera","year":"2022","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.jbc.2023.104886_bib25","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/emboj\/cdf327","article-title":"Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain","volume":"21","author":"Anand","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.jbc.2023.104886_bib26","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1021\/acscombsci.0c00058","article-title":"Targeting the dimerization of the main protease of coronaviruses: a potential broad-spectrum therapeutic strategy","volume":"22","author":"Goyal","year":"2020","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.jbc.2023.104886_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s13238-011-1034-1","article-title":"Activation and maturation of SARS-CoV main protease","volume":"2","author":"Xia","year":"2011","journal-title":"Protein Cell"},{"key":"10.1016\/j.jbc.2023.104886_bib28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s42003-022-03084-7","article-title":"Modulation of the monomer-dimer equilibrium and catalytic activity of SARS-CoV-2 main protease by a transition-state analog inhibitor","volume":"5","author":"Nashed","year":"2022","journal-title":"Commun. Biol."},{"key":"10.1016\/j.jbc.2023.104886_bib29","doi-asserted-by":"crossref","first-page":"167876","DOI":"10.1016\/j.jmb.2022.167876","article-title":"Unmasking the conformational stability and inhibitor binding to SARS-CoV-2 main protease active site mutants and miniprecursor","volume":"434","author":"Kovalevsky","year":"2022","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2023.104886_bib30","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1021\/acsinfecdis.1c00237","article-title":"Recognition of divergent viral substrates by the SARS-CoV-2 main protease","volume":"7","author":"MacDonald","year":"2021","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jbc.2023.104886_bib31","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cmdc.201900107","article-title":"Covalent inhibition in drug discovery","volume":"14","author":"Ghosh","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.jbc.2023.104886_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167118","article-title":"A\u00a0crystallographic snapshot of SARS-CoV-2 main protease maturation process","volume":"433","author":"Noske","year":"2021","journal-title":"J.\u00a0Mol. Biol."},{"key":"10.1016\/j.jbc.2023.104886_bib33","doi-asserted-by":"crossref","first-page":"12997","DOI":"10.1073\/pnas.1601327113","article-title":"SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity","volume":"113","author":"Muramatsu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.104886_bib34","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.1038\/s41467-020-19662-4","article-title":"Crystallographic structure of wild-type SARS-CoV-2 main protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site","volume":"11","author":"Lee","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104886_bib35","doi-asserted-by":"crossref","first-page":"13459","DOI":"10.1074\/jbc.M708506200","article-title":"Effect of the active site D25N mutation on the structure, stability, and ligand binding of the mature HIV-1 protease","volume":"283","author":"Sayer","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.jbc.2023.104886_bib36","doi-asserted-by":"crossref","first-page":"9072","DOI":"10.1073\/pnas.1102278108","article-title":"Inhibition of autoprocessing of natural variants and multidrug resistant mutant precursors of HIV-1 protease by clinical inhibitors","volume":"108","author":"Louis","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2023.104886_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.abb.2008.01.023","article-title":"Correlation between dissociation and catalysis of SARS-CoV main protease","volume":"472","author":"Lin","year":"2008","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.jbc.2023.104886_bib38","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/s41467-022-29915-z","article-title":"Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease","volume":"13","author":"Kneller","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104886_bib39","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/s41422-020-0356-z","article-title":"Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease","volume":"30","author":"Ma","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.jbc.2023.104886_bib40","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104886_bib41","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/s41467-021-20900-6","article-title":"A\u00a0small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication","volume":"12","author":"Hattori","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbc.2023.104886_bib42","series-title":"Enzymatic Reaction Mechanisms","author":"Walsh","year":"1979"},{"key":"10.1016\/j.jbc.2023.104886_bib43","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1021\/ja01004a021","article-title":"Nucleophilic reactivity constants toward methyl iodide and trans-dichlorodi(pyridine)platinum(II)","volume":"90","author":"Pearson","year":"1968","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.jbc.2023.104886_bib44","series-title":"Mechanism and Theory in Organic Chemistry","author":"Lowry","year":"1976"},{"key":"10.1016\/j.jbc.2023.104886_bib45","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1107\/S2052252521010113","article-title":"Michaelis-like complex of SARS-CoV-2 main protease visualized by room-temperature X-ray crystallography","volume":"8","author":"Kneller","year":"2021","journal-title":"IUCrJ"},{"key":"10.1016\/j.jbc.2023.104886_bib46","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1107\/S0907444913000061","article-title":"How good are my data and what is the resolution?","volume":"69","author":"Evans","year":"2013","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.104886_bib47","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.104886_bib48","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J.\u00a0Appl. Crystallogr."},{"key":"10.1016\/j.jbc.2023.104886_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.jbc.2023.104886_bib50","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/pro.3791","article-title":"Current developments in coot for macromolecular model building of electron cryo-microscopy and crystallographic data","volume":"29","author":"Casanal","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2023.104886_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1107\/S0907444909042073","article-title":"MolProbity: all-atom structure validation for macromolecular crystallography","volume":"66","author":"Chen","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.104886_bib52","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2023.104886_bib53","series-title":"Gaussian 16, Revision B.01","author":"Frisch","year":"2016"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823019142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925823019142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:37:56Z","timestamp":1762187876000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925823019142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0021925823019142"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104886","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2023.104886","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"104886"}}